<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34682970</PMID><DateRevised><Year>2021</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Comprehensive Examination of Severely Ill ME/CFS Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1290</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare9101290</ELocationID><Abstract><AbstractText>One in four myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients are estimated to be severely affected by the disease, and these house-bound or bedbound patients are currently understudied. Here, we report a comprehensive examination of the symptoms and clinical laboratory tests of a cohort of severely ill patients and healthy controls. The greatly reduced quality of life of the patients was negatively correlated with clinical depression. The most troublesome symptoms included fatigue (85%), pain (65%), cognitive impairment (50%), orthostatic intolerance (45%), sleep disturbance (35%), post-exertional malaise (30%), and neurosensory disturbance (30%). Sleep profiles and cognitive tests revealed distinctive impairments. Lower morning cortisol level and alterations in its diurnal rhythm were observed in the patients, and antibody and antigen measurements showed no evidence for acute infections by common viral or bacterial pathogens. These results highlight the urgent need of developing molecular diagnostic tests for ME/CFS. In addition, there was a striking similarity in symptoms between long COVID and ME/CFS, suggesting that studies on the mechanism and treatment of ME/CFS may help prevent and treat long COVID and vice versa.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chia-Jung</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, CA 94304, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Li-Yuan</ForeName><Initials>LY</Initials><Identifier Source="ORCID">0000-0002-0442-5829</Identifier><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Harvard, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kogelnik</LastName><ForeName>Andreas M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Basis Diagnostics, Newark, CA 94560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiyar</LastName><ForeName>Raeka S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, CA 94304, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Angela M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, CA 94304, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilhelmy</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, CA 94304, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Harvard, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tannenbaum</LastName><ForeName>Linda</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9885-4570</Identifier><AffiliationInfo><Affiliation>Open Medicine Foundation, Agoura Hills, CA 91301, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Wenzhong</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4944-6380</Identifier><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, CA 94304, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Harvard, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Ronald W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>ME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, CA 94304, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antibody and antigen</Keyword><Keyword MajorTopicYN="N">clinical symptoms</Keyword><Keyword MajorTopicYN="N">cognitive tests</Keyword><Keyword MajorTopicYN="N">laboratory tests</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae SARS-CoV-2 infection (PASC)</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">severe ME/CFS</Keyword><Keyword MajorTopicYN="N">sleep</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34682970</ArticleId><ArticleId IdType="pmc">PMC8535418</ArticleId><ArticleId IdType="doi">10.3390/healthcare9101290</ArticleId><ArticleId IdType="pii">healthcare9101290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Board on the Health of Select Populations. Institute of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Collection: Reports Funded by National Institutes of Health; National Academies Press (US); Washington, DC, USA: 2015.</Citation></Reference><Reference><Citation>Cortes Rivera M., Mastronardi C., Silva-Aldana C.T., Arcos-Burgos M., Lidbury B.A. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics. 2019;9:91. doi: 10.3390/diagnostics9030091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez A.R., Hancock E.E., Adebayo S., Kiernicki D.J., Proskauer D., Attewell J.R., Bateman L., DeMaria A., Lapp C.W., Rowe P.C., et al. Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning. Front. Pediatr. 2018;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00412</ArticleId><ArticleId IdType="pmc">PMC6331450</ArticleId><ArticleId IdType="pubmed">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Bested A.C., Bonilla H.F., Chheda B.V., Chu L., Curtin J.M., Dempsey T.T., Dimmock M.E., Dowell T.G., Felsenstein D., et al. Mayo Clinic Proceedings. Elsevier; Amsterdam, The Netherlands: 2021. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K., European Network on ME/CFS (EUROMENE) Chronic Viral Infections in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk Hvidberg M., Brinth L.S., Olesen A.V., Petersen K.D., Ehlers L. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) PLoS ONE. 2015;10:e0132421. doi: 10.1371/journal.pone.0132421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132421</ArticleId><ArticleId IdType="pmc">PMC4492975</ArticleId><ArticleId IdType="pubmed">26147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombardier C.H., Buchwald D. Outcome and Prognosis of Patients with Chronic Fatigue vs Chronic Fatigue Syndrome. Arch. Intern. Med. 1995;155:2105&#x2013;2110. doi: 10.1001/archinte.1995.00430190101014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1995.00430190101014</ArticleId><ArticleId IdType="pubmed">7575071</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson A., Hickie I., Lloyd A., Hadzi-Pavlovic D., Boughton C., Dwyer J., Wakefield D. Longitudinal Study of Outcome of Chronic Fatigue Syndrome. BMJ. 1994;308:756&#x2013;759. doi: 10.1136/bmj.308.6931.756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.308.6931.756</ArticleId><ArticleId IdType="pmc">PMC2539669</ArticleId><ArticleId IdType="pubmed">8142830</ArticleId></ArticleIdList></Reference><Reference><Citation>Fennell P.A., Jason L.A., Klein S.M. Capturing the Different Phases of the CFS Illness. CFIDS Chron. 1998;11:13&#x2013;16.</Citation></Reference><Reference><Citation>Pendergrast T., Brown A., Sunnquist M., Jantke R., Newton J.L., Strand E.B., Jason L.A. Housebound versus Nonhousebound Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Chronic Illn. 2016;12:292&#x2013;307. doi: 10.1177/1742395316644770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1742395316644770</ArticleId><ArticleId IdType="pmc">PMC5464362</ArticleId><ArticleId IdType="pubmed">27127189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiborg J.F., van der Werf S., Prins J.B., Bleijenberg G. Being Homebound with Chronic Fatigue Syndrome: A Multidimensional Comparison with Outpatients. Psychiatry Res. 2010;177:246&#x2013;249. doi: 10.1016/j.psychres.2010.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2010.02.010</ArticleId><ArticleId IdType="pubmed">20207012</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Division of High-Consequence Pathogens and Pathology (DHCPP)  Severely Affected Patients|Clinical Care of Patients|Healthcare Providers|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|CDC.  [(accessed on 22 August 2021)]; Available online:  https://www.cdc.gov/me-cfs/healthcare-providers/clinical-care-patients-mecfs/severely-affected-patients.html.</Citation></Reference><Reference><Citation>Dafoe W. Extremely Severe ME/CFS-A Personal Account. Healthc. Basel Switz. 2021;9:504. doi: 10.3390/healthcare9050504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9050504</ArticleId><ArticleId IdType="pmc">PMC8145314</ArticleId><ArticleId IdType="pubmed">33925566</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: When Suffering Is Multiplied. Healthcare. 2021;9:919. doi: 10.3390/healthcare9070919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9070919</ArticleId><ArticleId IdType="pmc">PMC8307552</ArticleId><ArticleId IdType="pubmed">34356297</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C.P., Speight N., Vallings R., et al. Myalgic Encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J.E., New England Medical Center Hospital. Health Institute . SF-36 Physical and Mental Health Summary Scales: A User&#x2019;s Manual. Health Institute, New England Medical Center; Boston, MA, USA: 1994.</Citation></Reference><Reference><Citation>Karnofsky D.A., Abelmann W.H., Craver L.F., Burchenal J.H. The Use of the Nitrogen Mustards in the Palliative Treatment of Carcinoma. With Particular Reference to Bronchogenic Carcinoma. Cancer. 1948;1:634&#x2013;656. doi: 10.1002/1097-0142(194811)1:4&lt;634::AID-CNCR2820010410&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(194811)1:4&lt;634::AID-CNCR2820010410&gt;3.0.CO;2-L</ArticleId></ArticleIdList></Reference><Reference><Citation>PROMIS: Patient-Reported Outcomes Measurement Information System&#x2014;Home Page.  [(accessed on 27 April 2021)]; Available online:  https://commonfund.nih.gov/promis/index.</Citation></Reference><Reference><Citation>Cella D., Yount S., Rothrock N., Gershon R., Cook K., Reeve B., Ader D., Fries J.F., Bruce B., Rose M., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group during Its First Two Years. Med. Care. 2007;45:S3&#x2013;S11. doi: 10.1097/01.mlr.0000258615.42478.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000258615.42478.55</ArticleId><ArticleId IdType="pmc">PMC2829758</ArticleId><ArticleId IdType="pubmed">17443116</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer B.R., Kleinman S., Wright D.J., Glynn S.A., Rye D.B., Kiss J.E., Mast A.E., Cable R.G., REDS-II RISE Analysis Group Restless Legs Syndrome, Pica, and Iron Status in Blood Donors. Transfusion (Paris) 2013;53:1645&#x2013;1652. doi: 10.1111/trf.12260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.12260</ArticleId><ArticleId IdType="pmc">PMC4226336</ArticleId><ArticleId IdType="pubmed">23763445</ArticleId></ArticleIdList></Reference><Reference><Citation>Finan P.H., Richards J.M., Gamaldo C.E., Han D., Leoutsakos J.M., Salas R., Irwin M.R., Smith M.T. Validation of a Wireless, Self-Application, Ambulatory Electroencephalographic Sleep Monitoring Device in Healthy Volunteers. J. Clin. Sleep Med. 2016;12:1443&#x2013;1451. doi: 10.5664/jcsm.6262.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.6262</ArticleId><ArticleId IdType="pmc">PMC5078698</ArticleId><ArticleId IdType="pubmed">27707438</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsleben J.A., Kapur V.K., Newman A.B., Shahar E., Bootzin R.R., Rosenberg C.E., O&#x2019;Connor G., Nieto F.J. Sleep and Reported Daytime Sleepiness in Normal Subjects: The Sleep Heart Health Study. Sleep. 2004;27:293&#x2013;298. doi: 10.1093/sleep/27.2.293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/27.2.293</ArticleId><ArticleId IdType="pubmed">15124725</ArticleId></ArticleIdList></Reference><Reference><Citation>Levendowski D.J., Ferini-Strambi L., Gamaldo C., Cetel M., Rosenberg R., Westbrook P.R. The Accuracy, Night-to-Night Variability, and Stability of Frontopolar Sleep Electroencephalography Biomarkers. J. Clin. Sleep Med. 2017;13:791&#x2013;803. doi: 10.5664/jcsm.6618.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.6618</ArticleId><ArticleId IdType="pmc">PMC5443740</ArticleId><ArticleId IdType="pubmed">28454598</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein S.M., Berten S., Olson P., Paul R., Willams L.M., Cooper N., Gordon E. Development and Validation of a World-Wide-Web-Based Neurocognitive Assessment Battery: WebNeuro. Behav. Res. Methods. 2007;39:940&#x2013;949. doi: 10.3758/BF03192989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BF03192989</ArticleId><ArticleId IdType="pubmed">18183911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon E., Cooper N., Rennie C., Hermens D., Williams L.M. Integrative Neuroscience: The Role of a Standardized Database. Clin. EEG Neurosci. 2005;36:64&#x2013;75. doi: 10.1177/155005940503600205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/155005940503600205</ArticleId><ArticleId IdType="pubmed">15999901</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Recommendations for Test Performance and Interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep. 1995;44:590&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">7623762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead P., Petersen J., Hinckley A. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep. 2019;68:703. doi: 10.15585/mmwr.mm6832a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6832a4</ArticleId><ArticleId IdType="pmc">PMC6818702</ArticleId><ArticleId IdType="pubmed">31415492</ArticleId></ArticleIdList></Reference><Reference><Citation>Magni R., Espina B.H., Shah K., Lepene B., Mayuga C., Douglas T.A., Espina V., Rucker S., Dunlap R., Petricoin E.F.I., et al. Application of Nanotrap Technology for High Sensitivity Measurement of Urinary Outer Surface Protein A Carboxyl-Terminus Domain in Early Stage Lyme Borreliosis. J. Transl. Med. 2015;13:346. doi: 10.1186/s12967-015-0701-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-015-0701-z</ArticleId><ArticleId IdType="pmc">PMC4634744</ArticleId><ArticleId IdType="pubmed">26537892</ArticleId></ArticleIdList></Reference><Reference><Citation>Theel E.S., Ross T. Seasonality of Bartonella Henselae IgM and IgG Antibody Positivity Rates. J. Clin. Microbiol. 2019;57:e01263-19. doi: 10.1128/JCM.01263-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01263-19</ArticleId><ArticleId IdType="pmc">PMC6879290</ArticleId><ArticleId IdType="pubmed">31533982</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. EClinicalMedicine. 2021:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan M.S., Dimulescu I., Murray J., Falkenberg V.R., Unger E.R. Pathway-Focused Genetic Evaluation of Immune and Inflammation Related Genes with Chronic Fatigue Syndrome. Hum. Immunol. 2015;76:553&#x2013;560. doi: 10.1016/j.humimm.2015.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2015.06.014</ArticleId><ArticleId IdType="pubmed">26116897</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;., Rekeland I.G., Lien K., Th&#xfc;rmer H., Borchgrevink P.C., Sch&#xe4;fer C., S&#xf8;rland K., A&#xdf;mus J., Ktoridou-Valen I., Herder I., et al. B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann. Intern. Med. 2019;170:585&#x2013;593. doi: 10.7326/M18-1451.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1451</ArticleId><ArticleId IdType="pubmed">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey: MANUAL and Interpretation Guide. Health Institute, New England Medical Center; Boston, MA, USA: 1993.</Citation></Reference><Reference><Citation>Tudor-Locke C.E., Myers A.M. Methodological Considerations for Researchers and Practitioners Using Pedometers to Measure Physical (Ambulatory) Activity. Res. Q. Exerc. Sport. 2001;72:1&#x2013;12. doi: 10.1080/02701367.2001.10608926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02701367.2001.10608926</ArticleId><ArticleId IdType="pubmed">11253314</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitt M.C., DuBose K.D., Ainsworth B.E., Tudor-Locke C. Walking Patterns in a Sample of African American, Native American, and Caucasian Women: The Cross-Cultural Activity Participation Study. Health Educ. Behav. Off. Publ. Soc. Public Health Educ. 2004;31:45S&#x2013;56S. doi: 10.1177/1090198104266034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1090198104266034</ArticleId><ArticleId IdType="pubmed">15296691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M.L., Bruck D. Sleep Abnormalities in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Review. J. Clin. Sleep Med. 2012;8:719&#x2013;728. doi: 10.5664/jcsm.2276.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.2276</ArticleId><ArticleId IdType="pmc">PMC3501671</ArticleId><ArticleId IdType="pubmed">23243408</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotts Z.M., Newton J.L., Ellis J.G., Deary V. The Experience of Sleep in Chronic Fatigue Syndrome: A Qualitative Interview Study with Patients. Br. J. Health Psychol. 2016;21:71&#x2013;92. doi: 10.1111/bjhp.12136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjhp.12136</ArticleId><ArticleId IdType="pubmed">25728396</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava D., Jung S., Saadat M., Sirohi R., Crewson K. How to Interpret the Results of a Sleep Study. J. Community Hosp. Intern. Med. Perspect. 2014;4:1&#x2013;4. doi: 10.3402/jchimp.v4.24983.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jchimp.v4.24983</ArticleId><ArticleId IdType="pmc">PMC4246141</ArticleId><ArticleId IdType="pubmed">25432643</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodoro T., Edwards M.J., Isaacs J.D. A Unifying Theory for Cognitive Abnormalities in Functional Neurological Disorders, Fibromyalgia and Chronic Fatigue Syndrome: Systematic Review. J. Neurol. Neurosurg. Psychiatry. 2018;89:1308&#x2013;1319. doi: 10.1136/jnnp-2017-317823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317823</ArticleId><ArticleId IdType="pmc">PMC6288708</ArticleId><ArticleId IdType="pubmed">29735513</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels V., de Gucht V., Cluydts R., Fischler B. Attention and Information Processing Efficiency in Patients with Chronic Fatigue Syndrome. J. Clin. Exp. Neuropsychol. 1999;21:709&#x2013;729. doi: 10.1076/jcen.21.5.709.875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/jcen.21.5.709.875</ArticleId><ArticleId IdType="pubmed">10572289</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmaling K.B., Betterton K.L. Neurocognitive Complaints and Functional Status among Patients with Chronic Fatigue Syndrome and Fibromyalgia. Qual. Life Res. 2016;25:1257&#x2013;1263. doi: 10.1007/s11136-015-1160-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-015-1160-y</ArticleId><ArticleId IdType="pmc">PMC6115195</ArticleId><ArticleId IdType="pubmed">26471263</ArticleId></ArticleIdList></Reference><Reference><Citation>OptumHealth. Brain Resource Company . WebNeuro User Manual. Brain Resource Company (BRC); San Francisco, CA, USA: 2008.</Citation></Reference><Reference><Citation>Nacul L.C., Lacerda E.M., Campion P., Pheby D., de Drachler L.M., Leite J.C., Poland F., Howe A., Fayyaz S., Molokhia M. The Functional Status and Well Being of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Their Carers. BMC Public Health. 2011;11:402. doi: 10.1186/1471-2458-11-402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-11-402</ArticleId><ArticleId IdType="pmc">PMC3123211</ArticleId><ArticleId IdType="pubmed">21619607</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves W.C., Wagner D., Nisenbaum R., Jones J.F., Gurbaxani B., Solomon L., Papanicolaou D.A., Unger E.R., Vernon S.D., Heim C. Chronic Fatigue Syndrome&#x2014;A Clinically Empirical Approach to Its Definition and Study. BMC Med. 2005;3:19. doi: 10.1186/1741-7015-3-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-3-19</ArticleId><ArticleId IdType="pmc">PMC1334212</ArticleId><ArticleId IdType="pubmed">16356178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L., Brown M., Evans M., Anderson V., Lerch A., Brown A., Hunnell J., Porter N. Measuring Substantial Reductions in Functioning in Patients with Chronic Fatigue Syndrome. Disabil. Rehabil. 2011;33:589&#x2013;598. doi: 10.3109/09638288.2010.503256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288.2010.503256</ArticleId><ArticleId IdType="pmc">PMC3170036</ArticleId><ArticleId IdType="pubmed">20617920</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L., Authier F.J., Scheibenbogen C., Lorusso L., Helland I.B., Martin J.A., Sirbu C.A., Mengshoel A.M., Polo O., Behrends U., et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe. Medicina. 2021;57:510. doi: 10.3390/medicina57050510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050510</ArticleId><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>US ME/CFS Clinician Coalition  . ME/CFS Treatment Recommendations. The US ME/CFS Clinician Coalition; 2021.  [(accessed on 22 August 2021)].  Version 1. Available online:  https://mecfscliniciancoalition.org.</Citation></Reference><Reference><Citation>Ross S., Fantie B., Straus S.F., Grafman J. Divided Attention Deficits in Patients with Chronic Fatigue Syndrome. Appl. Neuropsychol. 2001;8:4&#x2013;11. doi: 10.1207/S15324826AN0801_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/S15324826AN0801_2</ArticleId><ArticleId IdType="pubmed">11388122</ArticleId></ArticleIdList></Reference><Reference><Citation>US ME/CFS Clinician Coalition  . Testing Recommendations for Suspected ME/CFS. The US ME/CFS Clinician Coalition; 2021.  [(accessed on 22 August 2021)].  Version 1. Available online:  https://mecfscliniciancoalition.org.</Citation></Reference><Reference><Citation>Nater U.M., Maloney E., Boneva R.S., Gurbaxani B.M., Lin J.-M., Jones J.F., Reeves W.C., Heim C. Attenuated Morning Salivary Cortisol Concentrations in a Population-Based Study of Persons with Chronic Fatigue Syndrome and Well Controls. J. Clin. Endocrinol. Metab. 2008;93:703&#x2013;709. doi: 10.1210/jc.2007-1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2007-1747</ArticleId><ArticleId IdType="pubmed">18160468</ArticleId></ArticleIdList></Reference><Reference><Citation>Nater U.M., Youngblood L.S., Jones J.F., Unger E.R., Miller A.H., Reeves W.C., Heim C. Alterations in Diurnal Salivary Cortisol Rhythm in a Population-Based Sample of Cases with Chronic Fatigue Syndrome. Psychosom. Med. 2008;70:298&#x2013;305. doi: 10.1097/PSY.0b013e3181651025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0b013e3181651025</ArticleId><ArticleId IdType="pubmed">18378875</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.L.M.C., Rowe P.C., Visser F.C. Blood Volume Status in ME/CFS Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results. Front. Pediatr. 2018;6:352. doi: 10.3389/fped.2018.00352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00352</ArticleId><ArticleId IdType="pmc">PMC6262290</ArticleId><ArticleId IdType="pubmed">30525014</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D.S., Rea T.D., Katon W.J., Russo J.E., Ashley R.L. Acute Infectious Mononucleosis: Characteristics of Patients Who Report Failure to Recover. Am. J. Med. 2000;109:531&#x2013;537. doi: 10.1016/S0002-9343(00)00560-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(00)00560-X</ArticleId><ArticleId IdType="pubmed">11063953</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz B.Z., Shiraishi Y., Mears C.J., Binns H.J., Taylor R. Chronic Fatigue Syndrome after Infectious Mononucleosis in Adolescents. Pediatrics. 2009;124:189&#x2013;193. doi: 10.1542/peds.2008-1879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1879</ArticleId><ArticleId IdType="pmc">PMC2756827</ArticleId><ArticleId IdType="pubmed">19564299</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J., Chia A., Voeller M., Lee T., Chang R. Acute Enterovirus Infection Followed by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Viral Persistence. J. Clin. Pathol. 2010;63:165&#x2013;168. doi: 10.1136/jcp.2009.070466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2009.070466</ArticleId><ArticleId IdType="pubmed">19828908</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal A.J., Hanson M.R. The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review. Front. Med. 2021;8:688486. doi: 10.3389/fmed.2021.688486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.688486</ArticleId><ArticleId IdType="pmc">PMC8253308</ArticleId><ArticleId IdType="pubmed">34222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., for the Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2021;7:1132. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>